Search
for
Sort by
Research 121–150 of 1000+
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Novel Compound Heterozygous Variants in the CDC6 Gene in a Russian Patient with Meier-Gorlin Syndrome
- Industry Updates from the Field of Stem Cell Research and Regenerative Medicine in December 2019
- Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force
- Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications
- Food Bioactive Compounds and Emerging Techniques for Their Extraction: Polyphenols as a Case Study
- Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- RNA Coding and Transcriptional Regulation in Skin Repair: Insights from Single-Cell Profiling and Implications for Organoid-Based Regenerative Strategies
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Innovations in Skin and Soft Tissue Aging—A Systematic Literature Review and Market Analysis of Therapeutics and Associated Outcomes
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Differential impact of environmental factors on systemic and localized autoimmunity
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Evaluación de la seguridad de minoxidil oral a dosis bajas en el tratamiento de la alopecia
- Patrones tricoscópicos de las alopecias cicatrizales
- Signaling in the stem cell niche: regulating cell fate, function and plasticity
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- A use-and-transformation model for evaluating public R&D: Illustrations from polycystic ovarian syndrome (PCOS) research
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Gap junctions in Turing-type periodic feather pattern formation